Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Meso Scale Discovery U-PLEX Human BCMA/TNFRSF17 ASY
SDP

Catalog No. 5000082060
Encompass

The Meso Scale Discovery U-PLEX Human BCMA (TNFRSF17) Assay is an electrochemiluminescent immunoassay for the quantitative measurement of BCMA in human serum plasma and cell culture supernatants It utilizes MSD s proprietary SULFO-TAG labels and multi-array technology to provide sensitive and reproducible results for BCMA levels between 0 156 pg/mL to 10 000 pg/mL This assay can be used to monitor BCMA levels in research related to multiple myeloma autoimmune diseases and immune system function The kit includes a 96-well plate coated with capture antibodies detection antibodies calibrators controls 10X read buffer sample diluent and plate seals

Catalog No. 50-000-82060 Supplier Meso Scale Discovery Supplier No. K151D8K1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The Meso Scale Discovery U-PLEX Human BCMA (TNFRSF17) Assay is an electrochemiluminescent immunoassay for the quantitative measurement of BCMA in human serum plasma and cell culture supernatants It utilizes MSD s proprietary SULFO-TAG labels and multi-array technology to provide sensitive and reproducible results for BCMA levels between 0 156 pg/mL to 10 000 pg/mL This assay can be used to monitor BCMA levels in research related to multiple myeloma autoimmune diseases and immune system function The kit includes a 96-well plate coated with capture antibodies detection antibodies calibrators controls 10X read buffer sample diluent and plate seals

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.